Well it broke $2.00 today...at least intra-day...lots of time until the close.
Took a little time to read their latest filing.
Laughable strategy of in-licensing or buying a drug for development. Where does that money come from and what quality product can they get for the funding they have ? Even with little up front they would have to give away big royalties. Also, what is going on with the drug that they still have left ? why cant they just focus on that ? I smell the usual stench from PSTV as CYTX.
Anyway...I read fast...does anyone know the current outstanding share count ? That is what I was really looking for.
1. They still have to defend themselves against the TAP Advisors lawsuit.
2. Full debt payments set to start in 6 months...May 1 2020...assuming no renegotiation.